Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Arbuckle Stuart A | EVP, COO | May 15 '24 | Sale | 430.93 | 69 | 29,734 | 49,691 | May 17 04:24 PM | ALTSHULER DAVID | EVP, Chief Scientific Officer | May 15 '24 | Sale | 430.93 | 54 | 23,270 | 25,813 | May 17 04:22 PM | Sachdev Amit | EVP Chief Patient & Ext Af Off | May 15 '24 | Sale | 430.93 | 32 | 13,790 | 55,325 | May 17 04:27 PM | Bhatia Sangeeta N. | Director | May 02 '24 | Sale | 402.95 | 467 | 188,178 | 4,435 | May 03 04:05 PM | Ambrose Kristen | SVP & Chief Accounting Officer | Apr 02 '24 | Sale | 419.00 | 240 | 100,560 | 7,500 | Apr 03 04:02 PM | Arbuckle Stuart A | EVP, COO | Feb 26 '24 | Sale | 425.70 | 5,034 | 2,142,974 | 49,691 | Feb 27 04:37 PM | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 26 '24 | Sale | 425.70 | 4,239 | 1,804,542 | 25,813 | Feb 27 04:24 PM | Sachdev Amit | EVP Chief Patient & Ext Af Off | Feb 26 '24 | Sale | 425.70 | 3,004 | 1,278,803 | 55,325 | Feb 27 04:59 PM | Ambrose Kristen | SVP & Chief Accounting Officer | Feb 26 '24 | Sale | 425.70 | 883 | 375,893 | 7,965 | Feb 27 04:29 PM | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Feb 26 '24 | Sale | 425.70 | 883 | 375,893 | 15,972 | Feb 27 04:44 PM | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Feb 26 '24 | Sale | 425.70 | 354 | 150,698 | 55,804 | Feb 27 05:02 PM | Arbuckle Stuart A | EVP, COO | Feb 21 '24 | Sale | 421.77 | 3,603 | 1,519,637 | 59,439 | Feb 23 04:12 PM | Sachdev Amit | EVP Chief Patient & Ext Af Off | Feb 21 '24 | Sale | 421.77 | 3,191 | 1,345,868 | 60,798 | Feb 23 04:20 PM | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 21 '24 | Sale | 421.77 | 3,002 | 1,266,154 | 34,022 | Feb 23 04:10 PM | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Feb 21 '24 | Sale | 421.77 | 1,201 | 506,546 | 18,509 | Feb 23 04:16 PM | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Feb 21 '24 | Sale | 421.77 | 360 | 151,837 | 59,467 | Feb 23 04:28 PM | Arbuckle Stuart A | EVP, COO | Feb 20 '24 | Sale | 420.79 | 4,804 | 2,021,475 | 63,042 | Feb 21 04:19 PM | Sachdev Amit | EVP Chief Patient & Ext Af Off | Feb 20 '24 | Sale | 420.79 | 4,254 | 1,790,041 | 63,989 | Feb 21 04:38 PM | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 20 '24 | Sale | 420.79 | 4,002 | 1,684,002 | 37,024 | Feb 21 04:13 PM | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Feb 20 '24 | Sale | 420.79 | 801 | 337,053 | 19,710 | Feb 21 04:23 PM | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Feb 20 '24 | Sale | 420.79 | 480 | 201,979 | 59,827 | Feb 21 04:43 PM | LEIDEN JEFFREY M | Executive Chairman | Feb 15 '24 | Sale | 419.16 | 4,655 | 1,951,190 | 17,896 | Feb 16 04:07 PM | LEIDEN JEFFREY M | Executive Chairman | Feb 14 '24 | Sale | 419.04 | 4,356 | 1,825,338 | 22,551 | Feb 16 04:07 PM | LEIDEN JEFFREY M | Executive Chairman | Feb 13 '24 | Sale | 419.13 | 737 | 308,899 | 26,907 | Feb 14 04:04 PM | Arbuckle Stuart A | EVP, COO | Feb 12 '24 | Sale | 420.24 | 4,295 | 1,804,931 | 75,718 | Feb 13 04:51 PM | Sachdev Amit | EVP Chief Patient & Ext Af Off | Feb 12 '24 | Sale | 420.24 | 3,222 | 1,354,013 | 74,364 | Feb 13 05:15 PM | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 12 '24 | Sale | 420.24 | 3,145 | 1,321,655 | 47,588 | Feb 13 04:46 PM | LEIDEN JEFFREY M | Executive Chairman | Feb 12 '24 | Sale | 419.51 | 2,656 | 1,114,205 | 27,644 | Feb 14 04:04 PM | Biller Jonathan | EVP and Chief Legal Officer | Feb 12 '24 | Sale | 418.77 | 1,738 | 727,822 | 18,280 | Feb 13 04:56 PM | Ambrose Kristen | SVP & Chief Accounting Officer | Feb 12 '24 | Sale | 420.24 | 1,374 | 577,410 | 9,676 | Feb 13 04:48 PM | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Feb 12 '24 | Sale | 420.24 | 913 | 383,679 | 23,137 | Feb 13 04:54 PM | LEIDEN JEFFREY M | Executive Chairman | Jan 08 '24 | Sale | 419.07 | 6,648 | 2,785,977 | 2,423 | Jan 10 04:06 PM | WAGNER CHARLES F JR | EVP & Chief Financial Officer | Jan 02 '24 | Sale | 405.00 | 3,000 | 1,215,000 | 43,693 | Jan 04 04:17 PM | Kewalramani Reshma | CEO & President | Dec 15 '23 | Option Exercise | 181.83 | 17,135 | 3,115,593 | 125,846 | Dec 19 04:15 PM | Kewalramani Reshma | CEO & President | Dec 15 '23 | Sale | 407.00 | 17,135 | 6,973,945 | 108,711 | Dec 19 04:15 PM | Arbuckle Stuart A | EVP, COO | Dec 13 '23 | Option Exercise | 187.53 | 8,603 | 1,613,321 | 65,159 | Dec 15 04:20 PM | LEIDEN JEFFREY M | Executive Chairman | Dec 13 '23 | Sale | 399.42 | 13,354 | 5,333,799 | 9,071 | Dec 15 04:33 PM | Arbuckle Stuart A | EVP, COO | Dec 13 '23 | Sale | 399.00 | 8,603 | 3,432,597 | 56,556 | Dec 15 04:20 PM | Kewalramani Reshma | CEO & President | Dec 13 '23 | Sale | 397.00 | 5,098 | 2,023,906 | 108,711 | Dec 15 04:23 PM | WAGNER CHARLES F JR | EVP & Chief Financial Officer | Nov 20 '23 | Sale | 349.88 | 3,000 | 1,049,640 | 46,693 | Nov 21 04:07 PM | Sachdev Amit | EVP Chief Patient & Ext Af Off | Nov 15 '23 | Sale | 369.92 | 35 | 12,947 | 58,814 | Nov 17 04:16 PM | ALTSHULER DAVID | EVP, Global Research and CSO | Nov 15 '23 | Sale | 369.92 | 19 | 7,028 | 32,038 | Nov 17 04:11 PM | Bozic Carmen | EVP and CMO | Nov 14 '23 | Sale | 380.82 | 5,650 | 2,151,633 | 29,302 | Nov 16 04:15 PM | Kewalramani Reshma | CEO & President | Nov 13 '23 | Sale | 377.00 | 5,097 | 1,921,569 | 113,809 | Nov 15 04:16 PM | SACHS BRUCE I | Director | Nov 06 '23 | Option Exercise | 127.54 | 11,250 | 1,434,825 | 51,250 | Nov 08 04:11 PM | SACHS BRUCE I | Director | Nov 06 '23 | Sale | 385.00 | 11,250 | 4,331,250 | 40,000 | Nov 08 04:11 PM | Bozic Carmen | EVP and CMO | Oct 31 '23 | Sale | 355.92 | 5,651 | 2,011,304 | 34,952 | Nov 02 04:07 PM | Bozic Carmen | EVP and CMO | Oct 17 '23 | Sale | 373.25 | 5,651 | 2,109,236 | 40,603 | Oct 19 04:18 PM | Bhatia Sangeeta N. | Director | Oct 17 '23 | Sale | 375.00 | 243 | 91,125 | 3,901 | Oct 19 04:13 PM | LEIDEN JEFFREY M | Executive Chairman | Oct 16 '23 | Sale | 374.00 | 12,962 | 4,847,788 | 22,425 | Oct 18 04:17 PM | Bhatia Sangeeta N. | Director | Oct 06 '23 | Sale | 360.00 | 242 | 87,120 | 4,144 | Oct 11 04:14 PM | Bozic Carmen | EVP and CMO | Oct 03 '23 | Sale | 345.28 | 5,651 | 1,951,177 | 46,254 | Oct 05 04:30 PM | Biller Jonathan | EVP and Chief Legal Officer | Oct 02 '23 | Sale | 346.76 | 610 | 211,524 | 10,569 | Oct 03 04:07 PM | Bozic Carmen | EVP and CMO | Sep 19 '23 | Sale | 351.00 | 5,651 | 1,983,501 | 51,905 | Sep 21 04:15 PM | Bozic Carmen | EVP and CMO | Sep 05 '23 | Sale | 352.66 | 5,651 | 1,992,882 | 57,556 | Sep 07 04:29 PM | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Aug 23 '23 | Sale | 355.00 | 2,500 | 887,500 | 48,637 | Aug 25 04:14 PM | Kearney Terrence C | Director | Aug 10 '23 | Option Exercise | 127.54 | 10,000 | 1,275,400 | 16,536 | Aug 14 04:09 PM | Sachdev Amit | EVP, Chief Patient Officer | Aug 10 '23 | Sale | 350.00 | 10,031 | 3,510,850 | 58,814 | Aug 14 04:05 PM | Kearney Terrence C | Director | Aug 10 '23 | Sale | 350.00 | 10,000 | 3,500,000 | 6,536 | Aug 14 04:09 PM | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Aug 10 '23 | Sale | 345.79 | 5,750 | 1,988,293 | 51,137 | Aug 14 04:08 PM | Bhatia Sangeeta N. | Director | Aug 09 '23 | Sale | 345.51 | 242 | 83,613 | 4,386 | Aug 11 04:05 PM | ALTSHULER DAVID | EVP, Global Research and CSO | Aug 09 '23 | Sale | 345.51 | 63 | 21,767 | 32,038 | Aug 11 04:05 PM | SACHS BRUCE I | Director | Jul 17 '23 | Option Exercise | 127.54 | 11,250 | 1,434,825 | 51,250 | Jul 18 04:17 PM | SACHS BRUCE I | Director | Jul 17 '23 | Sale | 356.75 | 11,250 | 4,013,459 | 40,000 | Jul 18 04:17 PM | Kewalramani Reshma | CEO & President | Jul 17 '23 | Sale | 355.00 | 7,828 | 2,778,940 | 118,906 | Jul 18 04:13 PM | Arbuckle Stuart A | EVP, COO | Jun 15 '23 | Option Exercise | 187.53 | 8,603 | 1,613,321 | 65,159 | Jun 20 04:07 PM | Arbuckle Stuart A | EVP, COO | Jun 15 '23 | Sale | 349.00 | 8,603 | 3,002,447 | 56,556 | Jun 20 04:07 PM | Ambrose Kristen | SVP & Chief Accounting Officer | May 30 '23 | Sale | 329.82 | 289 | 95,318 | 6,838 | Jun 01 04:12 PM | Arbuckle Stuart A | EVP, COO | May 30 '23 | Sale | 329.82 | 82 | 27,045 | 56,556 | Jun 01 04:16 PM |
|